Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: A spectrum of sclerodermatous skin disease
- 1 December 1990
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 23 (6) , 1063-1069
- https://doi.org/10.1016/0190-9622(90)70334-e
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Silica-induced sclerodermaJournal of the American Academy of Dermatology, 1990
- Tryptophan-Induced Eosinophilia–Myalgia SyndromeNew England Journal of Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- L-Tryptophan: A Rational Anti-Depressant and a Natural Hypnotic?Australian & New Zealand Journal of Psychiatry, 1988
- Eosinophilia Associated With Perimyositis and PneumonitisMayo Clinic Proceedings, 1988
- ScleromyxedemaMedicine, 1988
- Fasciitis and polyarthritis during antituberculous therapyArthritis & Rheumatism, 1985
- Development of a Scleroderma-like Illness during Therapy with L-5-Hydroxytryptophan and CarbidopaNew England Journal of Medicine, 1980
- 5-Hydroxytryptamine: A Cytospecific Growth Stimulator of Cultured FibroblastsScience, 1970